HI
MRNA icon

Hudock Inc’s Moderna MRNA Stock Holding History

Hudock Inc’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-153
Closed -$18K – 493
2022
Q3 		$18K Hold
153
– – 0.01% 450
2022
Q2 		$21K Hold
153
– – 0.01% 416
2022
Q1 		$26K Buy
153
+2
+1% +$337 0.01% 406
2021
Q4 		$38K Sell
151
-17
-10% -$4.97K 0.01% 356
2021
Q3 		$64K Sell
168
-14
-8% -$5.16K 0.02% 289
2021
Q2 		$42K Sell
182
-2
-1% -$357 0.01% 345
2021
Q1 		$24K Buy
184
+29
+19% +$4.2K 0.01% 422
2020
Q4 		$16K Buy
+155
New +$15.7K 0.01% 453
2019
Q4 		– Sell
-1,096
Closed -$17K – 702
2019
Q3 		$17K Buy
+1,096
New +$16.2K 0.01% 376
2019
Q1 		– Sell
-1,000
Closed -$14K – 692
2018
Q4 		$14K Buy
+1,000
New +$16.4K 0.01% 353

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Hudock Inc's MRNA Position: Q4 2022 in Review

Hudock Inc sold out of Moderna (MRNA) in Q4 2022, closing a stake of 153 shares — an estimated $18K sold.

Hudock Inc first reported a position in MRNA in Q4 2018 and held it in 10 quarters. The position peaked at $64K in Q3 2021. 1,071 funds tracked by Wall St. Rank hold MRNA as of Q4 2022.

  • Hudock Inc reported no remaining Moderna position as of Q4 2022 after selling out during the quarter.
  • Hudock Inc sold 153 Moderna shares in Q4 2022, an estimated $18K.
  • Hudock Inc first reported a position in Moderna in Q4 2018 and held it in 10 quarters.
  • Hudock Inc's Moderna position peaked at $64K in Q3 2021.
  • 1,071 funds tracked by Wall St. Rank held Moderna as of Q4 2022.

Based on Hudock Inc's 13F filing for Q4 2022, filed 8 Feb 2023.